These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36765690)

  • 1. Sialyl Lewis
    Pascoal C; Carrascal MA; Barreira DF; Lourenço RA; Granjo P; Grosso AR; Borralho P; Braga S; Videira PA
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.
    Maeda T; Nakanishi Y; Hirotani Y; Fuchinoue F; Enomoto K; Sakurai K; Amano S; Nemoto N
    Med Mol Morphol; 2016 Mar; 49(1):11-21. PubMed ID: 26009308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis.
    Ilie SM; Bacinschi XE; Botnariuc I; Anghel RM
    Breast Cancer (Dove Med Press); 2018; 10():177-194. PubMed ID: 30538542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of EGFR and cytokeratin 5/6 immunohistochemical expression in triple-negative breast cancer.
    Abdelrahman AE; Rashed HE; Abdelgawad M; Abdelhamid MI
    Ann Diagn Pathol; 2017 Jun; 28():43-53. PubMed ID: 28648939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum levels of sialyl Lewis X (sLe
    Cohen EN; Fouad TM; Lee BN; Arun BK; Liu D; Tin S; Gutierrez Barrera AM; Miura T; Kiyokawa I; Yamashita J; Alvarez RH; Valero V; Woodward WA; Shen Y; Ueno NT; Cristofanilli M; Reuben JM
    Breast Cancer Res Treat; 2019 Aug; 176(3):545-556. PubMed ID: 31054033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Androgen Receptor Expression Selects for Basal-Like Phenotype and Is a Predictor of Poor Clinical Outcome in Non-Metastatic Triple Negative Breast Cancer.
    Riaz N; Idress R; Habib S; Lalani EN
    Front Oncol; 2020; 10():1083. PubMed ID: 32850312
    [No Abstract]   [Full Text] [Related]  

  • 7. Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.
    Julien S; Ivetic A; Grigoriadis A; QiZe D; Burford B; Sproviero D; Picco G; Gillett C; Papp SL; Schaffer L; Tutt A; Taylor-Papadimitriou J; Pinder SE; Burchell JM
    Cancer Res; 2011 Dec; 71(24):7683-93. PubMed ID: 22025563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population.
    Hashmi AA; Naz S; Hashmi SK; Hussain ZF; Irfan M; Bakar SMA; Faridi N; Khan A; Edhi MM
    BMC Res Notes; 2018 Jun; 11(1):372. PubMed ID: 29884220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer.
    Ferreira IG; Carrascal M; Mineiro AG; Bugalho A; Borralho P; Silva Z; Dall'olio F; Videira PA
    Int J Oncol; 2019 Nov; 55(5):1033-1048. PubMed ID: 31793656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
    Sheng J; Xue X; Jiang K
    Curr Mol Med; 2019; 19(2):147-155. PubMed ID: 30854965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfibril associated protein 4 (MFAP4) is a carrier of the tumor associated carbohydrate sialyl-Lewis x (sLe
    Guerrero PE; Duran A; Ortiz MR; Castro E; Garcia-Velasco A; Llop E; Peracaula R
    J Proteomics; 2021 Jan; 231():104004. PubMed ID: 33038510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
    Yue Y; Astvatsaturyan K; Cui X; Zhang X; Fraass B; Bose S
    PLoS One; 2016; 11(3):e0149661. PubMed ID: 26930401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.
    Li Q; Jin W; Cai Y; Yang F; Chen E; Ye D; Wang Q; Guan X
    Biochem Biophys Res Commun; 2017 Apr; 485(3):693-697. PubMed ID: 28237701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cancer-Associated Antigens Sialyl Lewis
    Dall'Olio F; Pucci M; Malagolini N
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinome-Wide siRNA Screening Identifies DYRK1B as a Potential Therapeutic Target for Triple-Negative Breast Cancer Cells.
    Chang CC; Chiu CC; Liu PF; Wu CH; Tseng YC; Lee CH; Shu CW
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.
    Ren X; Yuan L; Shen S; Wu H; Lu J; Liang Z
    Tumour Biol; 2016 Aug; 37(8):11385-95. PubMed ID: 26968553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASMT Regulates Tumor Metastasis Through the Circadian Clock System in Triple-Negative Breast Cancer.
    Xie F; Wang L; Liu Y; Liu Z; Zhang Z; Pei J; Wu Z; Zhai M; Cao Y
    Front Oncol; 2020; 10():537247. PubMed ID: 33194597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer.
    Tian Y; Sun X; Cheng G; Ji E; Yang S; Feng J; Zheng L
    Ann Transl Med; 2021 Jan; 9(2):131. PubMed ID: 33569433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.